These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31073547)

  • 1. Persistent Poor Metabolic Profile in Postmenopausal Women With Ovarian Hyperandrogenism After Testosterone Level Normalization.
    Rocha T; Crespo RP; Yance VVR; Hayashida SA; Baracat EC; Carvalho F; Domenice S; Mendonca BB; Gomes LG
    J Endocr Soc; 2019 May; 3(5):1087-1096. PubMed ID: 31073547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies.
    Yance VRV; Marcondes JAM; Rocha MP; Barcellos CRG; Dantas WS; Avila AFA; Baroni RH; Carvalho FM; Hayashida SAY; Mendonca BB; Domenice S
    Eur J Endocrinol; 2017 Jul; 177(1):93-102. PubMed ID: 28432270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours.
    Pelusi C; Forlani G; Zanotti L; Gambineri A; Pasquali R
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):533-8. PubMed ID: 22583337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism.
    Castelo-Branco C; Steinvarcel F; Osorio A; Ros C; Balasch J
    Gynecol Endocrinol; 2010 Oct; 26(10):736-42. PubMed ID: 20569105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis.
    Mamoojee Y; Ganguri M; Taylor N; Quinton R
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):13-20. PubMed ID: 28980338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Challenges in Ovarian Hyperthecosis: Clinical Presentation with Subdiagnostic Testosterone Levels.
    Shah S; Torres C; Gharaibeh N
    Case Rep Endocrinol; 2022; 2022():9998807. PubMed ID: 35087692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism.
    Meczekalski B; Szeliga A; Maciejewska-Jeske M; Podfigurna A; Cornetti P; Bala G; Adashi EY
    Gynecol Endocrinol; 2021 Aug; 37(8):677-682. PubMed ID: 33759685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone agonist treatment in postmenopausal women with hyperandrogenism of ovarian origin.
    Vollaard ES; van Beek AP; Verburg FA; Roos A; Land JA
    J Clin Endocrinol Metab; 2011 May; 96(5):1197-201. PubMed ID: 21307133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and ultrasound characteristics of virilizing ovarian tumors in pre- and postmenopausal patients: a single tertiary center experience.
    Zou M; Chen R; Wang Y; He Y; Wang Y; Dong Y; Li J
    Orphanet J Rare Dis; 2021 Oct; 16(1):426. PubMed ID: 34641931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
    Falsetti L; Pasinetti E
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Ovarian Hyperthecosis in a Postmenopausal Woman.
    Yousaf S; Nizar R; John L; Simpson A
    JCEM Case Rep; 2023 Nov; 1(6):luad148. PubMed ID: 38077307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipid profile comparison between pre- and post-menopausal women].
    Wang N; Qin MZ; Cui J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):799-804. PubMed ID: 27667280
    [No Abstract]   [Full Text] [Related]  

  • 15. Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women.
    Bahaeldein E; Brassill MJ
    Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 30481153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.
    Pinola P; Lashen H; Bloigu A; Puukka K; Ulmanen M; Ruokonen A; Martikainen H; Pouta A; Franks S; Hartikainen AL; Järvelin MR; Morin-Papunen L
    Hum Reprod; 2012 Nov; 27(11):3279-86. PubMed ID: 22933528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the diagnostic criteria of gestational metabolic syndrome and analysis of the risk factors].
    Niu JM; Lei Q; Lü LJ; Wen JY; Lin XH; Duan DM; Chen X; Zhou YH; Mai CY; Liu GC; Hou MM; Zhao LN; Yi J
    Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):92-7. PubMed ID: 23544488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare case of postmenopausal hyperandrogenism due to ovarian hyperthecosis and hilus cell hyperplasia.
    Johnson JE; Hussain M; Rathore A; Wolfe K
    Post Reprod Health; 2022 Mar; 28(1):51-55. PubMed ID: 35144514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low leptin level in an obese hyperandrogenic woman--potential marker for androgen-secreting tumor.
    Cvijovic G; Yamashita SA; Micic D; Kendereski A; Sumarac-Dumanovic M; Zoric S; Popovic V
    Gynecol Endocrinol; 2007 Feb; 23(2):112-6. PubMed ID: 17454162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.